The Inflammatory Bowel Disease Yearbook – Volume 7
As treatments advance, medical professionals are likely to face ethical and practical issues. For example, as more gene mutations associated with inflammatory bowel disease (IBD) are discovered, clinicians must determine when it is appropriate to pursue genetic testing, and how to best respond to patient queries. Many questions still remain regarding the optimal use of anti-tumor necrosis factor therapy in IBD. And how important is mucosal healing as a marker of comprehensive therapy?
These issues and more are discussed in The Inflammatory Bowel Disease Yearbook Volume 7, a concise, informative review of key issues in the management of IBD.
· Gastrointestinal manifestations of primary immunodeficiency disorders
· Genetic testing for IBD: current knowledge and implications for the future
· Pouchitis: risk factors, diagnosis, and treatment
· Optimizing anti-tumor necrosis factor therapy in IBD
· Laparoscopic surgery for IBD
· Mucosal healing in IBD: does it matter after all?